To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension
Phase 2
Recruiting
- Conditions
- Difficult to Control Hypertension
- Interventions
- Other: Placebo Matched control
- First Posted Date
- 2024-04-02
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- E-Star BioTech, LLC
- Target Recruit Count
- 120
- Registration Number
- NCT06343298
- Locations
- ๐บ๐ธ
Amicis Research Center - Granada Hills, Granada Hills, California, United States
๐บ๐ธInterventional Cardiology Medical Group, West Hills, California, United States
๐บ๐ธOffice of Dr. Edward Portnoy MD, Westlake Village, California, United States
Safety And Tolerability Of Subcutaneous MANP In Difficult To Control/Resistant Hypertensive Subjects
Phase 1
Completed
- Conditions
- Resistant HypertensionDifficult to Control Hypertension
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-02-21
- Last Posted Date
- 2022-11-29
- Lead Sponsor
- E-Star BioTech, LLC
- Target Recruit Count
- 37
- Registration Number
- NCT05247528
- Locations
- ๐บ๐ธ
USA Clinical Site 01, Tustin, California, United States
๐บ๐ธUSA Clinical Site 04, Decatur, Georgia, United States
๐บ๐ธUSA Clinical Site 05, Owensboro, Kentucky, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath